Chemically-stabilized allosteric modulators of leucine-rich repeat kinase 2 (lrrk2)

Eileen Kennedy (Inventor), Arjan Kortholt (Inventor), Leah G Helton (Inventor)

Research output: Patent

26 Downloads (Pure)

Abstract

The present disclosure describes synthetic polypeptides for the inhibition or modulation of the activity of leucine-rich repeat kinase 2 (LRRK2) along with methods of using the same in the treatment of medical conditions, for example neurological diseases or disorders.
Original languageEnglish
Patent numberWO2021173802
Priority date25/02/2020
Filing date25/02/2021
Publication statusPublished - 2-Sept-2021

Fingerprint

Dive into the research topics of 'Chemically-stabilized allosteric modulators of leucine-rich repeat kinase 2 (lrrk2)'. Together they form a unique fingerprint.

Cite this